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Abstract 
 
Objective 
To explore the relative frequency of a family history of cholesteatoma in patients with 
known cholesteatoma, and whether bilateral disease or earlier diagnosis are more likely in 
those with a family history. Associations between cleft lip or palate and bilateral disease and 
age of diagnosis were also explored.  
 
Design 
An online survey of patients with diagnosed cholesteatoma was conducted between 
October 2017 and April 2019.  
 
Participants 
The sample consisted of patients recruited from two UK clinics and self-selected 
respondents recruited internationally via social media. 
 
Main outcome measures 
Side of cholesteatoma, whether respondents had any family history of cholesteatoma, age 
of diagnosis and personal or family history of cleft lip or palate were recorded. 
 
Results 
Of 857 respondents 89 (10.4%) reported a positive family history of cholesteatoma. 
Respondents with a family history of cholesteatoma were more likely to have bilateral 
cholesteatoma (p=0.001, odds ratio (OR) 2.15, 95% confidence interval (CI) 1.35 to 3.43), 
but there was no difference in the age of diagnosis (p=0.23). Those with a history of cleft lip 
or palate were not more likely to have bilateral disease (p=0.051, OR 2.71, CI 1.00 to 7.38), 
and there was no difference in age of diagnosis (p=0.11). 
 
Conclusion 
The relatively high proportion of respondents that reported a family history of 
cholesteatoma offers supporting evidence of heritability in cholesteatoma. The use of social 
media to recruit respondents to this survey means that the results cannot be generalised to 
other populations with cholesteatoma. Further population-based research is suggested to 
determine the heritability of cholesteatoma.  
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Introduction 
 
Background 
Cholesteatoma is a well-defined erosive lesion of the middle ear, composed of keratinising 
squamous epithelium. It is a chronic condition affecting both children and adults with the 
only definitive treatment being microsurgery to clear it from the middle ear cleft. 
Cholesteatoma occurs in approximately 9.2 in 100,000 people per year in Northern Europe 
[1] with a peak incidence in the age group 5-15 years [2]. Cholesteatoma incidence is higher 
in men compared to women [1, 3] and also reported to be higher in white than non-white 
populations [4]. While cholesteatoma can be described as a rare disorder it is an important 
cause of acquired deafness. 
 
A systematic review of the genetics of cholesteatoma [5] was conducted and identified a 
range of studies reporting familial clustering. Whilst supportive of a genetic predisposition 
to cholesteatoma there was not enough evidence to describe cholesteatoma as a heritable 
trait. The review hypothesised that subtypes of cholesteatoma may exist with different 
aetiological pathways and suggested there may be rare genetic variants that underlie the 
disease in some families.  
 
Subsequently, the Genetics of Cholesteatoma (GoC) project 
(https://www.uea.ac.uk/rhinology-group/research/active-projects) established a database 
and sample bank with the aim of identifying candidate genetic variants of interest that co-
segregate with a cholesteatoma diagnosis in families with several affected individuals. 
Whole exome sequencing of DNA collected from participants in one family revealed variants 
of interest in two genes [6].  However, these are preliminary studies, and the variants are of 
unknown significance to the disease pathology. Any inherited risk for a complex trait like 
cholesteatoma is likely to be polygenic in origin; but a rare variant with a major functional 
effect may be a significant risk factor in some families. 
 
There have been numerous reports of associations between cholesteatoma and congenital 
conditions, namely cleft palate disorders and Turner syndrome. A Danish study found a 20-
fold increase in the risk of cholesteatoma for those with cleft palate [7] and a Canadian 
study reported an even higher 200-fold increase in the rate of acquired cholesteatoma 
when comparing children with cleft lip and palate to the baseline rate [8]. There have also 
been reports that individuals who have a sibling with palate problems are more likely to 
have cholesteatoma [7]. Similarly, strong associations between cholesteatoma and Turner 
syndrome have been reported [9, 10]. One study found that 7 out of 179 (3.9%) individuals 
with Turner syndrome had cholesteatoma [10] and another reported 26 out of 173 (15%) 
individuals with Turner syndrome had cholesteatoma [9].  
 
Objectives 
 
This study aims to explore the relative frequency of a family history of cholesteatoma in 
patients with established cholesteatoma, and whether bilateral disease or earlier diagnosis 
are more likely in those with a positive family history. Associations between cleft lip or 
palate and bilateral disease and age of diagnosis were also explored.  
 
Other hypothesis-generating associations are described in supplementary tables, namely 
whether a history of grommet insertion or tonsillectomy is associated with a younger age of 
cholesteatoma diagnosis.   
 
 
 
Materials and Methods 
 
Ethical considerations 
Ethical approval was granted by the Health Research Authority, East of England, Cambridge 
Central Research Ethics Committee (reference REC 16/EE/0131, IRAS ID 186786).  
 
Study design 
An online survey (http://smartsurvey.co.uk/s/cholesteatoma) was created to gather 
information from those who have been diagnosed with cholesteatoma and gathered 
retrospective data on demographics, genetic factors and condition specific factors.  
 
Setting 
Initially data collection focused on patients presenting in Norfolk to ENT clinics at two sites. 
Patients with a diagnosis of cholesteatoma were personally invited to complete the 
questionnaire. Subsequently the project was expanded globally, whereby anyone in the 
world could complete the survey if they had access to an online computer. The survey 
continues to collect responses from participants.  
 
Participants 
Participants were included if they had a diagnosis of cholesteatoma, had the capacity to 
consent to participation and were English speaking. There was no age restriction with some 
parents completing the survey on their child’s behalf. Participants were excluded if they did 
not complete the majority of the questionnaire (at least 11 questions).  
 
Variables 
Demographic questions encompassed; age, sex, ethnic background, geographic distribution, 
occupation and level of qualification. Questions regarding the genetic nature of the 
condition focused on whether there was any family history of cholesteatoma, palate 
problems or inherited medical conditions. Condition specific questions were also included in 
the survey and explored side of disease, age of diagnosis, history of other ear, nose or sinus 
conditions (including grommet insertion and tonsillectomy/adenoidectomy) and 
handedness (supplementary tables 1 and 2). Survey questions are summarised in 
supplementary table 4.  
 
Data sources 
Data were collected via a web based questionnaire over a 19-month period between October 
2017 and April 2019. The survey consisted of 24 closed questions each with a selection of 
available answers. Twelve questions provided open text boxes with the option to provide 
further details. Respondents could provide their postcode or country of origin in a free field 
text box.  Participants were either invited following a hospital clinic visit or self-selected 
through invitations posted in patient support groups on social media. Social media groups 
were identified by searching social media sites for groups with the word ‘cholesteatoma’ in 
their title. These groups were then contacted and asked if they would share the invitation to 
participate, and the survey link, with their members.  
 
Bias 
To ensure respondents had a cholesteatoma diagnosis they were asked at the beginning of 
the questionnaire to confirm if they had been invited to participate following a clinic visit or 
that they had a diagnosis of cholesteatoma and came across the survey online. 
 
Study Size 
Data collection was based on an online survey and no pre-set target was set.  
 
Quantitative variables 
Most of the questionnaire consisted of questions with categorical answers. Quantitative 
variables collected included age at completion of survey and age at diagnosis of 
cholesteatoma.  
 
Statistical methods 
The software package SPSS was used to generate descriptive statistics and conduct t-tests, 
chi-squared tests and logistic regression. Independent samples t-test was used to compare 
the average age and Chi-squared tests were conducted for each demographic category to 
compare differences between participants recruited online and from clinic. Subsequent 
analysis was conducted on the sample as a whole – combining participants from clinic and 
online.  
 
Logistic regression was performed to compare unilateral and bilateral disease to any family 
history of cholesteatoma, having a first degree relative with cholesteatoma and personal or 
family history of cleft lip/palate. T-tests were conducted to determine any difference in 
mean age of diagnosis for those with a family history of cholesteatoma and other past 
medical history (supplementary table 3).  
 
 
 
Results 
 
Participants 
A total of 859 participants completed the survey. Two respondents were excluded as they 
failed to complete the survey, answering at most 5 of 22 questions. The sample consisted of 
857 participants, 581 (68%) of which were female. The majority, 796 (93%), were recruited 
online as opposed to clinic. The mean age of diagnosis was 24.6 years of age, with a range of 
0 to 80 years (table 1). There was a peak in the age of diagnosis in childhood in the age range 
3-10 years old.  
 
Descriptive data 
Participants recruited online had a different gender distribution compared to the clinic 
participants; with a higher proportion of females (69.2%) than males (30.7%) compared to 
the almost even distribution of the clinic sample (table 1; p=0.002). Clinic and online recruits 
had a similar age range, though the mean ages differed (table 1; 44.5 years and 33.1 years 
retrospectively, p<0.001). Both samples had the same mean age of diagnosis (table 1; 24.6 
years, p=0.98). 
 
A substantial proportion of participants stated they lived in the UK (552/857,64.4%). Over a 
quarter of participants (215/857, 25.1%) did not state where they originated from. There 
clinic recruits were all from the UK, whereas the online recruits consisted of both UK and 
international participants (table 1; p<0.001).  
 
There was a range in the level of qualifications for the participants, with most having 
achieved GCSE or above. It must be noted that the sample included children, whom 
naturally will not have gained qualifications. The online recruits had on average higher levels 
of qualifications compared to the clinic recruits (table 1, p<0.001).  There was an almost 
equal distribution in terms of right or left ear affected (40% and 37% retrospectively), 
194/857 (23%) had both ears affected and there was no difference between online or clinic 
participants (Table 1; p=0.46).   
 
Outcome data  
When participants were asked whether they had a family member with cholesteatoma 89 of 
857 (10.4%) answered ‘yes’, 47 (5.5%) of these stating it was a first degree relative. In terms 
of cleft palate or lip condition, 39 (4.6%) said they had a family history of cleft lip/palate and 
16 (1.9%) stated they had this condition. 
 
Main results  
There was a positive association between participants reporting an affected family member 
(any relation) and bilateral cholesteatoma, those with an affected family member were 
more likely to have bilateral cholesteatoma than those with no such family history (table 2; 
OR 2.15, CI 1.35 to 3.43). Similarly, those with an affected first degree relative were more 
likely to have bilateral disease compared to those without such history (table 2; OR 2.04, CI 
1.10 to 3.80). Those with a personal history of cleft lip/palate were not more likely to have 
bilateral disease (table 2; p=0.051,OR 2.71, CI 1.00 to 7.38). There was no association 
between having a family history of cleft lip/palate and bilateral disease (table 2; OR 1.55, CI 
0.77 to 3.13).  
 
There was no difference in mean age of diagnosis between those with a family history (any 
relative and first degree relative) and those without such history (p=0.23 (CI -1.39 to 6.08) 
and p=0.52 (-6.62 to 3.36) retrospectively). Similarly, there was no difference in mean age of 
diagnosis for those with a cleft lip/palate or a family history of this condition (p=0.11 (CI -
1.61 to 15.12) and p=0.78 (CI -4.68 to 6.23) retrospectively). 
 
 
Discussion 
 
Key results 
Given that cholesteatoma is present in approximately 0.01% of the population it is 
interesting that 89 (10.4%) of 857 of respondents report an affected family member, 47 
(5.5%) of whom are first degree relatives. The association between family history of 
cholesteatoma and bilateral disease is a novel finding of this study.  
 
There was no evidence in the sample of a positive association between a personal history of 
cleft lip/palate and bilateral ear disease, though the small number of participants with such 
history suggests these results should be considered with caution. There was also no 
evidence in the sample that a family history of cholesteatoma or a history of cleft lip/palate 
resulted in a younger mean age of cholesteatoma diagnosis.  
 
Interpretation 
The number of respondents whom reported a family history of cholesteatoma is consistent 
with studies that report familial clustering and the suspicion of cholesteatoma as a heritable 
trait [5]. The association between family history of cholesteatoma and bilateral disease may 
represent a genetic liability, whereby those with a genetic predisposition are more likely to 
have more severe disease. It might be expected that those with a genetic predisposition for 
cholesteatoma would have a younger mean age of diagnosis, though this data does not 
support this hypothesis.   
 
Various studies have reported an association between cleft lip/palate and cholesteatoma [7, 
8]. The sample of this study is consistent with this; with 16/857 (1.9%) reporting to have had 
a cleft lip/palate problem themselves. Given that the incidence of cleft lip/palate in 
newborn babies in the UK is 1.7 per 1000 [12], or 0.17%, the proportion of people in the 
sample who report to have cleft lip/palate is higher than would be expected 
 
This sample includes a large number of participants with a wide age range of 1-80 years. The 
2.1 to 1 female to male ratio differs from the widely reported higher incidence in men [1, 3, 
11]. The gender ratio may represent a bias in the sampling technique whereby there is likely 
to be gender differences in health seeking behaviour and social media engagement. The 
distribution of the age of diagnosis is consistent with other studies, with a peak in childhood 
[2, 3].  
 Limitations 
The opportunistic sampling method presents challenges in how widely the results can be 
generalised. Participants were self-selected and, for the majority, their diagnosis of 
cholesteatoma was self-reported. However, it can be argued that, given the rare nature of 
cholesteatoma, participants are unlikely to have self-diagnosed or have come across the 
survey by chance. Nevertheless, the survey relied on participants recalling details of their 
own diagnosis and past medical history.  
 
In addition, there were limitations in the survey design including that questions regarding 
qualifications were originally formatted for UK respondents, subsequent international 
distribution of the survey resulted in respondents having to convert their education level 
into UK answers. Ethnicity data had to be excluded due to ambiguity in the available 
categorical answers.  
 
Despite the limitations this study is a relatively large survey of people with cholesteatoma. 
The sample captured people throughout the world affected by the condition from the very 
young to older generation and included a wide range of data on demographic, genetic and 
condition specific factors.  
 
Generalisability 
The approach of gathering participants through social media may result in capturing a 
particular social demographic, as evidenced by the higher proportion of females that 
completed the survey. It is also possible that such an approach recruited individuals who are 
more affected by their condition, with more severe symptoms or who have more affected 
friends and family since those with cholesteatoma who have affected family members may 
be more likely to complete and share the survey. Nevertheless, the percentage that report 
an affected family member is much greater than what would be expected by chance. 
 
Conclusion 
This study aimed to explore genetic factors in cholesteatoma. A larger number than would 
be expected reported a positive family history of cholesteatoma and a personal or family 
history of cleft lip or palate. There was a positive association between having a family 
history of cholesteatoma and bilateral cholesteatoma.  
 
Implications of research  
This study offers further support for a genetic component to cholesteatoma and possible 
association with more severe disease. Preliminary findings of genetic based research have 
identified two gene variants of interest in cholesteatoma [6]. Further population based 
research is suggested to determine the heritability of cholesteatoma.  
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Key points 
• 89 of 857 (10.4%) of respondents with cholesteatoma reported an affected family 
member. 
• This study found a positive association between family history of cholesteatoma and 
bilateral cholesteatoma. 
• Further population based research is suggested to determine the heritability of 
cholesteatoma. 
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